Navigation Links
Pitt receives $2.8 million to train HIV/AIDS researchers in Mozambique, Brazil and India
Date:4/17/2009

PITTSBURGH, April 17 The University of Pittsburgh has received a five-year, $2.8 million grant from the National Institutes of Health's Fogarty International Center to train researchers in regions of the world most hard-hit by the HIV/AIDS epidemic. The grant, part of the center's AIDS International Training and Research Program (AITRP), will allow Pitt to develop a training site in Mozambique, where there are an estimated 750 new HIV infections every day, and to expand programs underway in Brazil and India.

"The HIV/AIDS epidemic remains uncontrolled in many regions in the world," said principal investigator Lee Harrison, M.D., professor of medicine and epidemiology, University of Pittsburgh. "With an ever-growing number of patients in treatment programs, there is an urgent need for well-trained scientists to monitor patients and find out why people develop resistance to anti-HIV drugs." He said the Fogarty grant will give international researchers the tools and skills needed to do this vital work.

"America has become the leader in advancing prevention and treatment of HIV/AIDS in developing countries," said Roger I. Glass, M.D., Ph.D., director of the Fogarty International Center. "Training local researchers benefits their own countries and helps U.S. scientists develop new understanding and methods for combating disease."

The Pitt training program in Mozambique is based on a partnership forged in 2006 with Catholic University Mozambique, the site of one of only two medical schools in the southeastern African country. With 1.8 million people living with HIV and one physician for every 33,000 residents, Mozambique has very limited capabilities for research and few trained investigators, Dr. Harrison said. The growing epidemic disproportionately impacts women, many of them of childbearing age. In the region of Beira, where Catholic University is based, 34 percent of pregnant women are HIV-infected.

In Mozambique, the Pitt team will focus on training researchers in epidemiological methods to better understand the failure of antiretroviral treatment and answer basic questions about HIV prevalence. In Brazil, ranked second in number of reported AIDS cases in the Americas, training will focus on treatment and vaccine trials, tuberculosis research related to AIDS and the effectiveness of antiretroviral therapy in public clinics. In India, where there are 2.5 million HIV-infected people, training will center on laboratory studies on the molecular mechanisms of HIV and the development of anti-HIV vaccines using Indian strains.

The University of Pittsburgh received one of seven AITRP grants recently awarded. The AITRP has trained nearly 2,000 researchers overseas, most of whom remain in their countries to continue HIV/AIDS research, train young scientists and provide leadership to their governments on health issues. Co-directing the program with Dr. Harrison is Phalguni Gupta, Ph.D., professor in the Department of Infectious Diseases and Microbiology at the University of Pittsburgh Graduate School of Public Health.


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Wellesse Receives Corporate Sponsor of the Year Award From the Arthritis Foundations Pacific Northwest Chapter
2. Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study
3. Zultys Inc. Receives 2009 NGN Leadership Award from NGN Magazine
4. Sage Intergy EHR Receives 08 CCHIT Certification
5. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
6. ExpressMD(TM) Solutions Remote Patient Health Monitoring Device Receives 510(K) Market Clearance Approval From FDA
7. Alseres Pharmaceuticals, Inc. Receives Notice of De-Listing of Its Securities for Failure to Regain Compliance with Continued Listing Requirements
8. Milton resident receives the Helen B. Spaulding Community Conscience Award
9. IDM Pharma Receives Nasdaq Shareholder Equity Notification
10. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
11. Xoft Receives Health Canada Regulatory Approval for the Axxent(R) Electronic Brachytherapy System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... Grocery Company to the list of fine retailers selling biodegradable, hanging flushable wipes ... H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates more than ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – ... just 19 hours without sleep can compromise motor reaction time, which can increase the risk ... Insurance is sharing the following tips from the NSF to help you sleep better and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... MA (PRWEB) , ... April 28, 2017 , ... People ... for older people. “Wearing a hearing aid doesn’t have the stigma it had when ... & Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
Breaking Medicine Technology: